Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

NCT04705597 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
194
Enrollment
INDUSTRY
Sponsor class

Stopped The incidence of COVID-19 hospitalization cases decreased to a level that continued enrollment was no longer feasible

Conditions

Interventions

Sponsor

BioAge Labs, Inc.